| Stem definition | Drug id | CAS RN |
|---|---|---|
| antiestrogens or estrogen receptor modulators, clomifene and tamoxifen derivatives | 4308 | 180916-16-9 |
| Dose | Unit | Route |
|---|---|---|
| 0.50 | mg | O |
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Feb. 24, 2009 | EMA | Dr. Friedrich Eberth Arzneimittel GmbH |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | G03XC03 | GENITO URINARY SYSTEM AND SEX HORMONES SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM Selective estrogen receptor modulators |
| CHEBI has role | CHEBI:35610 | antineoplastic agents |
| CHEBI has role | CHEBI:50646 | antiosteoporotic |
| CHEBI has role | CHEBI:50792 | estrogen receptor antagonists |
| CHEBI has role | CHEBI:63951 | estrogen receptor agonists |
| CHEBI has role | CHEBI:77307 | cardioprotective agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Postmenopausal osteoporosis | indication | 102447009 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.5 | acidic |
| pKa2 | 8.9 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Estrogen receptor | Nuclear hormone receptor | AGONIST | IC50 | 8.89 | CHEMBL | SCIENTIFIC LITERATURE | |||
| Estrogen receptor beta | Nuclear hormone receptor | AGONIST | IC50 | 8.74 | CHEMBL | SCIENTIFIC LITERATURE | |||
| Estrogen receptor | Transcription factor | IC50 | 7.95 | CHEMBL |
| ID | Source |
|---|---|
| D04672 | KEGG_DRUG |
| 190791-29-8 | SECONDARY_CAS_RN |
| C0963839 | UMLSCUI |
| CHEBI:135938 | CHEBI |
| C3D | PDB_CHEM_ID |
| CHEMBL328190 | ChEMBL_ID |
| DB06202 | DRUGBANK_ID |
| C111332 | MESH_SUPPLEMENTAL_RECORD_UI |
| 7542 | IUPHAR_LIGAND_ID |
| 7875 | INN_ID |
| 337G83N988 | UNII |
| 216416 | PUBCHEM_CID |
None